These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10194839)

  • 1. Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview.
    Kyd JM; Cripps AW
    Vaccine; 1999 Mar; 17(13-14):1775-81. PubMed ID: 10194839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D; Ogra PL
    Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis.
    Kyd J; John A; Cripps A; Murphy TF
    Vaccine; 1999 Oct; 18(5-6):398-406. PubMed ID: 10519928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against middle-ear bacterial and viral pathogens.
    Giebink GS
    Ann N Y Acad Sci; 1997 Dec; 830():330-52. PubMed ID: 9616694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.
    Cripps AW; Dunkley ML; Clancy RL
    Infect Immun; 1994 Apr; 62(4):1427-36. PubMed ID: 8132349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
    Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying vaccine antigens and assessing delivery systems for the prevention of bacterial infections.
    Kyd J; Cripps A
    J Biotechnol; 2000 Sep; 83(1-2):85-90. PubMed ID: 11000464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization against respiratory bacterial pathogens.
    Foxwell AR; Kyd JM; Cripps AW
    Expert Rev Vaccines; 2003 Aug; 2(4):551-60. PubMed ID: 14711339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An animal model to study the mechanisms of immunity induced in the respiratory tract by intestinal immunization.
    Cripps AW; Dunkley ML; Clancy RL; Wallace F; Buret A; Taylor DC
    Adv Exp Med Biol; 1995; 371B():749-53. PubMed ID: 7502891
    [No Abstract]   [Full Text] [Related]  

  • 10. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats.
    Akkoyunlu M; Forsgren A
    APMIS; 1996 Oct; 104(10):709-17. PubMed ID: 8980621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML; Arêas AP; Ho PL
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monophosphoryl lipid A enhances nontypeable Haemophilus influenzae-specific mucosal and systemic immune responses by intranasal immunization.
    Iwasaki T; Hirano T; Kodama S; Kadowaki Y; Moriyama M; Kawano T; Suzuki M
    Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():5-12. PubMed ID: 28483250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single nasal dose of CCL20 chemokine induces dendritic cell recruitment and enhances nontypable Haemophilus influenzae-specific immune responses in the nasal mucosa.
    Kodama S; Abe N; Hirano T; Suzuki M
    Acta Otolaryngol; 2011 Sep; 131(9):989-96. PubMed ID: 21534717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17-like immune response in fish mucosal tissues after administration of live attenuated Vibrio anguillarum via different vaccination routes.
    Zhang H; Shen B; Wu H; Gao L; Liu Q; Wang Q; Xiao J; Zhang Y
    Fish Shellfish Immunol; 2014 Apr; 37(2):229-38. PubMed ID: 24561130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An animal model demonstration of enhanced clearance of nontypable Haemophilus influenzae from the respiratory tract after antigen stimulation of gut-associated lymphoid tissue.
    Wallace FJ; Clancy RL; Cripps AW
    Am Rev Respir Dis; 1989 Aug; 140(2):311-6. PubMed ID: 2788377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moraxella catarrhalis-induced purulent otitis media in the rat middle ear. Structure, protection, and serum antibodies.
    Westman E; Melhus A; Hellström S; Hermansson A
    APMIS; 1999 Aug; 107(8):737-46. PubMed ID: 10515124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies of immunization against mucosal infections.
    Russell MW; Martin MH; Wu HY; Hollingshead SK; Moldoveanu Z; Mestecky J
    Vaccine; 2000 Dec; 19 Suppl 1():S122-7. PubMed ID: 11163475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immune system: implications in otitis media with effusion.
    Bernstein JM; Ogra PL
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):326-32. PubMed ID: 6778340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of nontypeable Haemophilus influenzae in mice.
    Siggins MK; Gill SK; Langford PR; Li Y; Ladhani SN; Tregoning JS
    Vaccine; 2015 Sep; 33(38):4954-61. PubMed ID: 26212006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal vaccination against bacterial respiratory infections.
    Baumann U
    Expert Rev Vaccines; 2008 Oct; 7(8):1257-76. PubMed ID: 18844598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.